ArticleCardiovascular diabetology2026

Cardioprotective glucose-lowering drugs, statins, and secondary major adverse cardiovascular events: a nationwide cohort study of individuals with type 2 diabetes and cardiovascular disease.

Tummas Ternhamar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.